Skip to main content
. 2020 Jun 19;19(3):203–212. doi: 10.1007/s11901-020-00527-9

Table 1.

Indications and contraindications for liver transplant

Indications
Acute liver failure
Hepatic artery thrombosis within 14 days of liver transplant
Cirrhosis with:
  Decompensation (variceal bleeding, hepatic encephalopathy, or ascites)
  MELD score ≥ 15
  Hepatopulmonary syndrome or portopulmonary hypertension (select patients)
Primary hepatic neoplasms:
  Hilar cholangiocarcinoma (highly selected, after neoadjuvant therapy protocol)
  Hepatocellular carcinoma within the Milan criteria
Inborn metabolic conditions:
  Cystic fibrosis with concomitant lung and liver disease
  Primary hyperoxaluria type I with significant renal insufficiency
  Familial amyloid polyneuropathy
Contraindications
Absolute contraindications
  Active extrahepatic malignancy
  Intrahepatic cholangiocarcinoma
  Hepatocellular carcinoma outside Milan criteria or metastatic
  Severe cardiopulmonary disease
  Uncontrolled sepsis
  Active alcohol or illicit substance abuse
  Acquired immune deficiency syndrome (AIDS)
  Persistent non-compliance or lack of social support
  Technical and/or anatomic barriers to liver transplantation
Relative contraindications
  Advanced age
  Portal venous thrombosis
  Human immunodeficiency virus (HIV) infection
  MELD score < 15
  Morbid obesity (body mass index [BMI] ≥ 40)
  Poor medical compliance or social support
  Active psychiatric comorbidities